eWallstreeter

Onyx Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 10:30 AM

Tue, 21 May 2013 20:50:08 EDT

ONYX Pharmaceuticals, Inc. (ONXX) May 21, 2013 10:30 am ET Executives Matthew K. Fust - Chief Financial Officer, Principal Accounting Officer and Executive Vice President Analysts Andrew Peters - UBS Investment Bank, Research Division Presentation Andrew Peters - UBS Investment Bank, Research Division Hello and good morning. My name is Andrew Peters, and I'm on the biotech equity research team here at UBS. I'd like to thank everyone for coming to the 2013 UBS Global Health Care Conference. It's my great pleasure this morning to introduce Matthew Fust, Executive Vice President and Chief Financial Officer of Onyx Pharmaceutical. Thank you. Matthew K. Fust Good morning. Thank you so much for that introduction, and thanks to all of you for joining us this morning to learn more about the Onyx story. I'm really pleased to have the opportunity to update you over the course of the next few minutes, as well <a href='http://seekingalpha.com/article/1451981-onyx-pharmaceuticals-inc-presents-at-ubs-global-healthcare-conference-may-21-2013-10-30-am?source=feed'>Complete Story »</a>

Australian shares rise after Wall St hits new all-time highs

Tue, 21 May 2013 20:20:24 EDT

SYDNEY, May 20 (Reuters) - Australian shares rose 0.4 percent on Wednesday, led by blue-chip miners after comments from U.S. Federal Reserve officials eased some concerns that the central bank might...

JPMorgan Chase & Co. Management hosts 2013 Annual Shareholders Meeting (Transcript)

Tue, 21 May 2013 19:56:01 EDT

JPMorgan Chase & Co (JPM) 2013 Annual Shareholders Meeting May 21, 2013 10:00 AM ET Executives Jamie Dimon - Chairman and CEO Steve Cutler - General Counsel Lisa Lindsley - AFSCME Michael Garland - New York City Comptroller's Office Lee Raymond Father Seamus Finn Analysts Eric Cohen - Shareholder Michael Mayo - CLSA William Patterson - CtW Investment Group Michael Pryce-Jones - CtW Investment Group Alan Fisher - California Reinvestment Coalition Leon Kamhi - Hermes Equity Ownership Services Andrew Pittman - Shareholder Manuel Isaza - Hermes Equity Ownership Services Inc. London George Bolus - Shareholder John Grandoff Mike Collins Steve Dennis Alexis Iwanisziw Presentation Jamie Dimon Good morning, it's my pleasure to call the annual meeting of the shareholders of JPMorgan Chase and Company; we welcome all of you here. I'm Jamie Dimon Chairman of the Board and Chief Executive Officer and the Chairman of this meeting. I do want <a href='http://seekingalpha.com/article/1451931-jpmorgan-chase-amp-co-management-hosts-2013-annual-shareholders-meeting-transcript?source=feed'>Complete Story »</a>

Weyerhaeuser Co. Presents at Goldman Sachs Basic Materials Conference 2013, May-21-2013 01:35 PM

Tue, 21 May 2013 19:50:10 EDT

Weyerhaeuser Co. (WY) May 21, 2013 1:35 pm ET Executives Daniel S. Fulton - Chief Executive Officer, President, Director and Member of Executive Committee Analysts Alex Ovshey Ovshey - Goldman Sachs Group Inc., Research Division Presentation Alex Ovshey Ovshey - Goldman Sachs Group Inc., Research Division We'll get started with our next presenter, Weyerhaeuser, a leading player in the wood products business, real estate and of course, the crown jewel of the company, the timberland. They also have exposure in fluff pulp. Very fortunate to have Dan Fulton, the CEO of the company, with us today. So I will turn it over to him to tell us more about the story. Dan? Daniel S. Fulton Thanks, Alex. We have a limited amount of time today. I want to thank everybody for being here. I'm going to start very quickly with a forward-looking statement and while you're memorizing that, just remind <a href='http://seekingalpha.com/article/1451911-weyerhaeuser-co-presents-at-goldman-sachs-basic-materials-conference-2013-may-21-2013-01-35-pm?source=feed'>Complete Story »</a>

Municipal Mortgage & Equity's CEO Discusses Q1 2013 Results - Earnings Call Transcript

Tue, 21 May 2013 19:41:03 EDT

Municipal Mortgage & Equity, LLC (MMAB.PK) Q1 2013 Earnings Conference Call May 21, 2013 04:30 PM ET Executives Michael L. Falcone - President and CEO Lisa Roberts - CFO Gary A. Mentesana - EVP and Chief Capital Officer Analysts Michael Leconey - Bishop, Rosen & Co., Inc. Presentation Operator Good afternoon, ladies and gentlemen and welcome to the Municipal Mortgage & Equity, LLC First Quarter Conference Call. My name is Mike, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We'll facilitate a question-and-answer session at the end of this conference call. Some comments today will include forward-looking statements regarding future events and projections of financial performance of MuniMae, which are based on current expectations. These comments are subject to significant risks, which include those identified in filings with the Securities and Exchange Commission, and uncertainties that could cause actual results <a href='http://seekingalpha.com/article/1451891-municipal-mortgage-amp-equity-s-ceo-discusses-q1-2013-results-earnings-call-transcript?source=feed'>Complete Story »</a>

Cell Therapeutics, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 02:30 PM

Tue, 21 May 2013 19:30:10 EDT

Cell Therapeutics, Inc. (CTIC) May 21, 2013 2:30 pm ET Executives James A. Bianco - Principal Founder, Chief Executive Officer, President and Executive Director Presentation Unknown Analyst So I'm [indiscernible]. I cover biotech space in Europe for UBS. I just would like to introduce Dr. Blanco, CEO for CTI. So you can have probably a 25 minutes presentation. James A. Bianco Thank you. Good afternoon. As is typical of the presentations of this variety, we will be making forward-looking statements and as such, we refer you to our SEC filings for more information on the company and its programs. As you may know, last year, we reentered the commercial realm of biotechnology with the approval of PIXUVRI in the EU as the first approved drug for patients who have failed 2 or 3 prior lines of therapy who have aggressive B-cell lymphoma. We launched that product. It's currently available in <a href='http://seekingalpha.com/article/1451881-cell-therapeutics-inc-presents-at-ubs-global-healthcare-conference-may-21-2013-02-30-pm?source=feed'>Complete Story »</a>

Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 12:30 PM

Tue, 21 May 2013 19:20:08 EDT

Sunesis Pharmaceuticals, Inc. (SNSS) May 21, 2013 12:30 pm ET Executives Eric H. Bjerkholt - Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Development & Finance and Corporate Secretary Presentation Unknown Analyst Hi, good afternoon, everyone. Thanks for coming. My name is Melanie Fan [ph], happy to be your host for this session. Our next presenter is Eric Bjerkholt from Sunesis Pharmaceuticals. There's going to be a breakout session immediately following his presentation in Liberty 1 and 2. Eric H. Bjerkholt All right. Thank you, Melanie. And thank you to UBS for inviting us to present. We are thrilled to be here and welcome to all of you to our presentation. So before I launch into this, let me first say that I will be making forward-looking statements today. So I refer you to our regulatory filings for a full list of risk factors. So at Sunesis, <a href='http://seekingalpha.com/article/1451861-sunesis-pharmaceuticals-inc-presents-at-ubs-global-healthcare-conference-may-21-2013-12-30-pm?source=feed'>Complete Story »</a>

Australia shares seen edging up on Wall St, miners may cap gains

Tue, 21 May 2013 19:16:40 EDT

SYDNEY, May 22 (Reuters) - Australian shares are seen edging higher on Wednesday, after comments from Federal Reserve officials eased some concerns that the central bank might scale back its stimulus...

Amicus Therapeutics' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)

Tue, 21 May 2013 19:14:07 EDT

Amicus Therapeutics, Inc. (FOLD) 2013 UBS Global Healthcare Conference Call May 21, 2013 1:30 PM ET Executives John Crowley – Chairman and CEO Analysts Matthew Roden - UBS Presentation Matthew Roden - UBS Good evening everyone. My name is Matt Roden. I am one of biotech analyst here at UBS and I'd like to thank everyone for attending the new UBS Global Healthcare Conference. I am pleased and privileged to introduce Amicus Therapeutics, an innovator in rare and orphan diseases. Speaking on behalf of Amicus is its Chairman and Chief Executive Officer, John Crowley. John was Founder, Chairman and CEO of Novazyme before its acquisition of Genzyme, prior to Amicus. He also has experience as a naval officer and at Bristol-Myers Squibb. But he is probably most well-known for his personal drive to find solutions for rare diseases. Following the presentation there is going to be a break-out in Liberty <a href='http://seekingalpha.com/article/1451841-amicus-therapeutics-ceo-presents-at-2013-ubs-global-healthcare-conference-transcript?source=feed'>Complete Story »</a>

Jim Cramer’s Play on a European Turnaround

Tue, 21 May 2013 19:04:00 EDT

If Europe turns, which Jim Cramer thinks it soon will, then this is THE play, the "Mad Money" host said.

Lightning Round: Toll Brothers, AES & More

Tue, 21 May 2013 18:58:00 EDT

It's time for the Lightning Round. Jim Cramer makes the call on viewer favorites.

Lakeland Industries Management Discusses Q4 2013 Results - Earnings Call Transcript

Tue, 21 May 2013 18:50:08 EDT

Lakeland Industries (LAKE) Q4 2013 Earnings Call May 21, 2013 4:30 pm ET Executives Christopher J. Ryan - Chief Executive Officer, President, Secretary and Director Gary Pokrassa - Chief Financial Officer Analysts Quinton Mathews Douglas Ruth Presentation Operator Good afternoon and welcome to the Lakeland Industries Investor Conference Call. [Operator Instructions] Please note this event is being recorded. Before we begin, parties are reminded that statements made during this call contain forward-looking information within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934. Forward-looking statements are all statements other than statements of historical fact, which reflect management's expectations regarding future events and operating performance and speak only as of today, May 21, 2013. Forward-looking statements are based on current assumptions and analysis made by the company in light of the experience and its perception of historical trends, current conditions, expected future developments and other <a href='http://seekingalpha.com/article/1451801-lakeland-industries-management-discusses-q4-2013-results-earnings-call-transcript?source=feed'>Complete Story »</a>

Triple-S Management's CEO Presents at UBS 2013 Global Healthcare Conference (Transcript)

Tue, 21 May 2013 18:49:04 EDT

Triple-S Management Corporation (GTS) UBS 2013 Global Healthcare Conference Call May 21, 2013, 03:00 pm ET Executives Ramón Ruiz-Comas - President & CEO Analysts Presentation Unidentified Analyst Okay. Good afternoon everyone. Thank you so much for coming to the 2013 UBS Global Healthcare Conference. My name is [Kenneth Sule] and I am happy to be your host for this session. We are very pleased to have with us today, Mr. Ramón Ruiz-Comas, the President and CEO of Triple-S Management. I just want to remind everyone that there will be breakout session in room Liberty III just down the hall right after the presentation. Thank you very much. Ramón Ruiz-Comas Good afternoon to everybody. First, let me thank all the folk of UBS for providing us with opportunity to present our company, talk and strategy to you today. Today, I am accompanied by Amílcar Jordán, our Chief Financial Officer and Alan <a href='http://seekingalpha.com/article/1451781-triple-s-management-s-ceo-presents-at-ubs-2013-global-healthcare-conference-transcript?source=feed'>Complete Story »</a>

Off the Charts: eBay

Tue, 21 May 2013 18:45:00 EDT

Mad Money host Jim Cramer takes a look at eBay's technicals.

Cramer: These IPOS May Be Worth Getting in on

Tue, 21 May 2013 18:34:00 EDT

There are two IPOs on Jim Cramer's radar. Here's why he think they may be worth getting in on.

3 Residential REITs Yielding More Than 14% To Fight Future Inflation

Tue, 21 May 2013 18:28:39 EDT

ByBlack Coral Research:The mortgage sector has been underperforming over the last few quarters due to QE3 measures taken by the government. But REIT stocks are beginning to rebound as mortgage rates increase along with the spread. Most of the companies in the sector reported declines in net interest rate spreads and were forced to cut dividends to stay afloat.Lately there have been some voices on the ill effects of the strategy and supporting a withdrawal of QE3. However, such a thing is not possible in the short run, but it may be time to analyze some of the REITs and take a position now to gain in the time ahead. Discussed below are three residential REITs with yield greater than 14%. Click to enlarge image. *As of May 20, 2013. Source: Finviz.com. ARMOUR Residential REIT, Inc. (ARR) is externally managed by Armour Residential Management LLC. ARR's main businessComplete Story »

Cadence's Management Presents at UBS Global Healthcare Conference (Transcript)

Tue, 21 May 2013 18:28:09 EDT

Cadence Pharmaceuticals Inc. (CADX) UBS Global Healthcare Conference Transcript May 21, 2013 2:00 PM ET Executives Bill LaRue - Chief Financial Officer Analysts Ami Fadia - UBS Presentation Ami Fadia - UBS … for joining us. I’m Ami Fadia. I cover mid-cap spec pharma stocks at UBS. And it’s my pleasure to have Bill LaRue, who is the Chief Financial Officer at Cadence Pharmaceuticals. Please come to floor. Bill LaRue All right. Thank you, Ami. Thank you everyone for joining today. I appreciate the opportunity. It’s been some time talking about the Cadence story. Before we start, I mentioned forward-looking statements, there are a number of risks inherent in our industry and our businesses and these risks are outlined in our Risk Factors contained in our periodic filings with the SEC, including our most recent 10-Q. So for those of you who are new to the story, Cadence Pharmaceuticals is <a href='http://seekingalpha.com/article/1451721-cadence-s-management-presents-at-ubs-global-healthcare-conference-transcript?source=feed'>Complete Story »</a>

Can WFM Compete on Price? CEO Explains

Tue, 21 May 2013 18:25:00 EDT

Walter Robb, Whole Foods Market co-CEO, says the company has one new store every week slated for the back half of 2013.

Cramer: What Home Depot Says About America, Stocks

Tue, 21 May 2013 18:19:00 EDT

Home Depot's earnings said a lot about America, Cramer said. It also gave him a treasure trove of investment ideas.

Breaking Down The Alerian Index Round II: Kinder Morgan Energy Partners

Tue, 21 May 2013 18:16:43 EDT

By Mike Maher:Continuing the dissection of the Alerian MLP Index, the second largest holding in the index is Kinder Morgan Energy Partners LP (KMP), making up 10.2% of AMZ. Kinder Morgan is really a family of companies, with a publicly traded GP, Kinder Morgan Inc. (KMI), and a sister company, KMR, that pays distributions in new units. The KMP units pay their distributions in cash, but are otherwise identical to Kinder Morgan Energy Management LLC (KMR), which pays distributions in additional units and makes up 3.8% of the Alerian Index. Since each ticker basically represents the same assets, its not as if owning both represents any diversification, so the same pipes in the ground represent 14% of AMZ.As I said, Kinder Morgan Inc is the GP of KMP, and adds a significant amount of growth opportunities, given its size. KMI also has helped facilitate the biggest development in the MLP spaceComplete Story »

Cisco Suddenly Popular With Investors And For Good Reason

Tue, 21 May 2013 18:11:09 EDT

ByBlack Coral Research:Cisco (CSCO) delivered an investor "quadfecta" when it reported its fiscal third quarter earnings last Thursday. Its earnings of 51 cents per share beat estimates by 2 cents, while its revenues of $12.2 billion were higher than the consensus estimate of $12.18 billion.Meanwhile, the networking giant also guided full-year revenues higher, saying the company could attain 4% to 7% growth even accounting for the sale of Linksys. The higher end of that range exceeds Wall Street's consensus of 6.8%. What's more, Cisco expects fiscal fourth quarter earnings of as much as 52 cents per share - a penny better than the current consensus estimate. Finally, Cisco announced that it was raising its dividends by 20% - a sign that the company is confident enough in its own future prospects that it is willing to return more cash to investors.Consequently, Cisco's stock, which had been one of the DowComplete Story »

Exact Sciences Corporation Presents at UBS Global Healthcare Conference, May-21-2013 10:30 AM

Tue, 21 May 2013 18:10:06 EDT

EXACT Sciences Corporation (EXAS) May 21, 2013 10:30 am ET Executives Kevin T. Conroy - Chief Executive Officer, President and Director Presentation Unknown Analyst Good morning, everyone. Thank you for coming to day 2 of the UBS Healthcare Conference. My name is David Suki [ph]. I'm with the healthcare investment banking team here at UBS in New York. It's my pleasure to introduce our next speaker, which is Kevin Conroy of Exact Sciences Corp. Following the presentation, there'll be a breakout session in room Liberty 3 down the hall. Kevin? Kevin T. Conroy Thank you very much. Very much appreciate being invited to speak today. Before I get going here, we will be making forward-looking statements. This is the Safe Harbor statement. We're here today to talk about Cologuard, which is a new test that screens for, not only colon cancer, but most importantly the precancers that lead to colon <a href='http://seekingalpha.com/article/1451661-exact-sciences-corporation-presents-at-ubs-global-healthcare-conference-may-21-2013-10-30-am?source=feed'>Complete Story »</a>

Mad Money, May 21, 2013

Tue, 21 May 2013 18:00:00 EDT

Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.

A Few Near-Term Catalysts To Consider When It Comes To Southern Company

Tue, 21 May 2013 17:59:36 EDT

ByHeather Ingrassia:On Monday May 20th it was announced that Southern Co. (SO) would be replacing the head of its Mississippi utility amid growing concern about the cost of its Kemper coal power plant whose estimated price tag has ballooned to $4.3B. General counsel Ed Holland has been named CEO of Mississippi Power following the sudden retirement of Ed Day, who had headed the utility since 2010. Southern Company took a total of $540 million in charges against earnings related to Kemper in Q1. As a result of the company's announcement regarding its Mississippi utility I wanted examine several of the reasons why I'm considering this higher-yielding utility play. Overview: Based in Atlanta, Georgia, Southern Company together with its subsidiaries operates as a public electric utility company. The company is involved in the generation, transmission, and distribution of electricity through coal, nuclear, oil and gas, and hydro resources in the Complete Story »

As National Oilwell Varco Ups Its Dividend, An Acquisition Could Enhance Its Revenue

Tue, 21 May 2013 17:59:09 EDT

ByHeather Ingrassia:On Monday, May 20, National Oilwell Varco (NOV) announced a quarterly dividend increase of $0.013/share to bring its upcoming dividend payout to $0.26/share. It should be noted that this increase represents a 100% increase from its prior dividend of $0.13/share, which was paid on March 29. In the wake of NOV's dividend increase I wanted to not only examine the company's Q1 results, but also highlight some of the key catalysts behind my decision to consider a long-term position in this particular luxury retail play. Overview Based in Houston, Texas, National Oilwell Varco provides equipment and components for oil and gas drilling and production, oilfield services, and supply chain integration services to the upstream oil and gas industry worldwide. On Monday shares of NOV, which currently possess a market cap of $29.28 billion, a P/E ratio of 12.28, a forward P/E ratio of 10.46, and a forward yield of 1.51%Complete Story »

General Electric Surges Near 2 Year High And It Will Go Even Higher

Tue, 21 May 2013 17:56:20 EDT

ByEquity Options Guru:In a market that continues to outperform, investors normally wouldn't give much thought to investing a conglomerate that carries a market cap of almost $250 billion. Investors would probably think that the stock has lost its luster and won't generate enough of a return to get excited about. However, General Electric (GE) has proven those investors wrong. With the stock on the verge of breaking out above a 2 year high, investors should consider investing in the company for the following reasons. Reason #1: Technical The company has been on absolute tear ever since the company announced its first quarter earnings. And that trend has also continued for the past 52 weeks, as the chart below shows. (Click to enlarge) General Electric's 52 week high is $23.90 and based on today's closing price, the share price is only $0.24 away from setting a 2 year high. The most impressive Complete Story »

Is Xbox One 'Game Over' For GameStop?

Tue, 21 May 2013 17:46:00 EDT

ByJohn Deamer:Microsoft (MSFT) unveiled the new Xbox One game console and it has a lot of bells and whistles. I'm going to ignore most of them for this article and look at one interesting item - used games and how it may affect GameStop (GME).A recent Wired article addressed some new issues with the console but here is one of interest to GameStop investors: "There's one feature of Xbox One from which we can infer quite a few conclusions: You can install any game from the disc to the console's hard drive, and then play that game whenever you like without having to put the disc in." Wired asked Microsoft if installation would be mandatory. "On the new Xbox, all game discs are installed to the HDD to play," the company responded in an emailed statement. Sounds mandatory to us.What follows naturally from this is that each discComplete Story »

Discover Financial Services Presents at Barclay's Americas Select Franchise Conference, May-21-2013 11:30 AM

Tue, 21 May 2013 17:40:07 EDT

Discover Financial Services (DFS) May 21, 2013 6:30 am ET Executives R. Mark Graf - Chief Financial Officer and Executive Vice President Analysts Mark C. DeVries - Barclays Capital, Research Division Presentation R. Mark Graf Thanks, Mark. It's a pleasure to be here with all of you today. I appreciate your taking the time and the interest you're showing in us very, very much. Let me begin by going over some very important disclosures. As I said, some of you heard me say before, they start off a bit slowly, but they do have a very strong finish, so stick with us, please. Really, on a serious note, I encourage you to review these important disclosures because all of my remarks today are conditioned upon them. Discover's strategic objective is to be the leading direct bank in the U.S. and the leading payments partner globally. We've made great progress toward <a href='http://seekingalpha.com/article/1451571-discover-financial-services-presents-at-barclay-s-americas-select-franchise-conference-may-21-2013-11-30-am?source=feed'>Complete Story »</a>

Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03:30 PM

Tue, 21 May 2013 17:40:07 EDT

Achillion Pharmaceuticals, Inc. (ACHN) May 21, 2013 3:30 pm ET Executives Mary Kay Fenton - Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Secretary Analysts Matthew Harrison - UBS Investment Bank, Research Division Presentation Matthew Harrison - UBS Investment Bank, Research Division Afternoon, everybody. I'm Matthew Harrison, one of the biotech analysts here at UBS. Happy to have Achillion presenting next. And we have the Chief Financial Officer, Mary Kay Fenton presenting. Thanks. Mary Kay Fenton Good afternoon, everyone. Thanks, Matthew, for having us this afternoon, and thank you for spending some time with Achillion. Let me see if I can just drive the presentation here. Well? Matthew Harrison - UBS Investment Bank, Research Division The green button on the controller. Mary Kay Fenton Yes. Ah. Thank you very much. So I do have to remind you, before we begin, that I will be making some forward-looking statements. <a href='http://seekingalpha.com/article/1451561-achillion-pharmaceuticals-inc-presents-at-ubs-global-healthcare-conference-may-21-2013-03-30-pm?source=feed'>Complete Story »</a>

Bull vs. Bear: Home Depot

Tue, 21 May 2013 17:40:00 EDT

Discussing whether you should be optimistic or cautious on Home Depot, with the Fast Money team. Meanwhile Patrick Chidley, HSBC, says you should buy gold miners.

Xbox? PS/4? The Big Winner Is AMD

Tue, 21 May 2013 17:39:49 EDT

ByTom Luongo:One of the two next-generation game consoles is going to kill it in the marketplace. With the battle for the living room just beginning, the real question on everyone's lips is, "Who will win?" Frankly, I don't care which one wins. Today Microsoft (MSFT) unveiled its latest Xbox, the Xbox One and for the non-hardcore gamer in your household it looks like they have built something worth considering. With the early announcement of the power of the SoC that runs Sony's (SNE) Playstation 4 and the reveal today it is pretty obvious that Microsoft has chosen to move in a different direction with the Xbox and that direction is only tenuously attached to gaming. Regardless of who winds up with the most market share in two or three years, the real winner in all of this is Advanced Micro Devices (AMD) as they are powering both of these consoles. AndComplete Story »

Regions Financial Corporation Presents at Barclay's Americas Select Franchise Conference, May-21-2013 10:00 AM

Tue, 21 May 2013 17:30:06 EDT

Regions Financial Corporation (RF) May 21, 2013 5:00 am ET Executives O. B. Grayson Hall - Chairman, Chief Executive Officer, President, Chief Executive Officer of Regions Bank, President of Regions Bank and Director of Regions Bank David J. Turner - Chief Financial Officer, Senior Executive Vice President, Member of The Executive Council, President of Central Region, Chief Financial Officer of Regions Bank and Senior Executive Vice President of Regions Bank Analysts Jason M. Goldberg - Barclays Capital, Research Division Presentation Jason M. Goldberg - Barclays Capital, Research Division Next up, very pleased to have Regions Financial. Regions is a company that, over the last several years, has made considerable progress, improving its balance sheet, managed franchise, which is concentrated in the southeastern portion of the United States, and now back to the point where it's improved its capital position so much, that it's now increasing its dividend and buying back <a href='http://seekingalpha.com/article/1451521-regions-financial-corporation-presents-at-barclay-s-americas-select-franchise-conference-may-21-2013-10-00-am?source=feed'>Complete Story »</a>

Dimon Wins the Rumble in Tampa

Tue, 21 May 2013 17:30:00 EDT

JPMorgan Chase shareholders reject a bid to split the chairman and CEO roles, with the Fast Money team. Jeff Weiss, Tejas Securities Group, charts weakness in gold.

Long Setup in Herbalife Still Attractive; Stock Breaks Out as New Auditor Hired

Tue, 21 May 2013 17:21:27 EDT

Few stocks have attracted more news over the last six months than nutritional supplement maker Herbalife (NYSE: HLF). Even casual market observers are aware of the circumstances surrounding the the initial bout of extreme volatility in the name back in December 2012. The shares went into free-fall at the end of the year after hedge fund manager Bill Ackman revealed in typical sanctimonious fashion that his firm Pershing Square Capital Management was short around $1 billion worth of the stock. Amid much pomp and circumstance, Ackman laid out his short thesis at a New York investment conference and immediately made the rounds in the financial media. The noted investor called the multi-level marketing company's business model a "pyramid scheme" and boldly proclaimed that his price target for the stock was "$0." The way that the Pershing Square founder went about attacking Herbalife sure made it seem like he was trying to inflict maximum damage to the company in a very short period of time. While Ackman's strategy was initially brutally effective, it quickly backfired on him. Herbalife shares swan-dived from above $42 on December 18, the day before the hedge fund manager's presentation, to a low of roughly $26 by Christmas Eve. The news caused the heaviest high-volume selling in Herbalife's history as a publicly traded company. The stock bounced back nearly as quickly as it plunged, however, as numerous other investors and market observers came out in support of the company. Herbalife itself also aggressively refuted Ackman's allegations. When two of the world's top hedge fund managers, Dan Loeb and Carl Icahn, revealed that their firms had bought large stakes in the Cayman Islands-based company ...

UPDATE 4-Sprint raises Clearwire offer, not enough for some

Tue, 21 May 2013 17:20:10 EDT

* Shareholder hopes for a deal price range from $3.70 to $7

Why Chesapeake's New CEO Makes It A Better Long

Tue, 21 May 2013 17:19:20 EDT

By Gary Bourgeault:After years of acquiring enormous assets which made Chesapeake Energy Corporation (CHK) second only to Exxon Mobil (XOM) in natural gas production, CEO and Chairman Aubrey McClendon, who founded the company, was forced to leave April 1, and has now been replaced by Anadarko Petroleum (APC) executive Robert Douglas Lawler.Who you may ask? We'll get into why the question itself, and the answer to the underlying premise of the question is important to this new CEO choice for Chesapeake.As most readers know, McClendon was pressured out by shareholders Carl C. Icahn and Southeastern Asset Management, with reports stating the unusual deal McClendon had in place which allowed, and still allows him, to acquire rights into wells of the company, being the catalyst.While that is asserted as the uproar that eventually removed McClendon from his leadership role, it's not the real cause, only the assumed andComplete Story »

Apple CEO Defends Tax Policy

Tue, 21 May 2013 17:15:00 EDT

Apple CEO Tim Cook hit back at Congress today, with the Fast Money team. Meanwhile CNBC's Jon Fortt weighs in on the $50 smartphone.

Can Skullcandy Turn The Dial Up To 11?

Tue, 21 May 2013 17:13:45 EDT

By Paid2Trade:Skullcandy (SKUL) finally found bottom after losing two thirds of its IPO valuation in mid-2011. The headphone maker initially opened for trading above $20 per share. Sadly, it has been a long, painful ride down for shareholders, who recently saw shares dip below $5 after posting first quarter results on May 2nd.Many thought a bottom might have been in place when shares started to trade strongly headed into the fourth quarter earnings back in February. While the results were good, the guidance was not. The CEO had just left the company and sales were estimated to be down ~30% year-over-year for the next quarter.Well, Skullcandy was pretty close to estimates this quarter, with sales down just under 30% from the previous quarter. Management mainly cited repackaging efforts and product rebranding for the lack of sales. It should also be noted that sales were not down merely for lackComplete Story »

Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AM

Tue, 21 May 2013 17:10:10 EDT

Jazz Pharmaceuticals, Inc. (JAZZ) May 21, 2013 9:30 am ET Executives Kathryn E. Falberg - Chief Financial Officer and Executive Vice President Analysts Ami Fadia - UBS Investment Bank, Research Division Presentation Ami Fadia - UBS Investment Bank, Research Division Good morning, everybody. Thanks for coming to the UBS Conference. I'm Ami Fadia. I cover mid-cap spec pharma stocks at UBS. It's my pleasure to have Kate, who is the CFO of Jazz Pharmaceuticals, to present. What we'll do is, if we have some time at the end, we might ask a few questions here. And then we'll take it to the breakout session. Thanks. Kathryn E. Falberg Thanks, Ami, and good morning, everyone. Thanks for joining us here today. With me today is Kathy Littrell, our Head of Investor Relations. So if you haven't met her yet, she's fairly new with the company. She's sitting there in the back <a href='http://seekingalpha.com/article/1451411-jazz-pharmaceuticals-public-limited-company-presents-at-ubs-global-healthcare-conference-may-21-2013-09-30-am?source=feed'>Complete Story »</a>

Relative Value Trade: Long Westjet, Short A Basket Of Airlines

Tue, 21 May 2013 16:58:11 EDT

ByIs It Worth It:With a single digit p/e (cash adjusted) and a small dividend yield, Westjet offers tremendous value in a seemingly over-valued market. We believe that due to its Canadian listing and Mid Capitalization size, Westjet is an overlooked undervalued growth stock.WestJet Airlines (WJAVF.PK) is a Canadian low-cost carrier that provides scheduled and chartered air services to 86 destinations in Canada, the USA, Mexico, Central America and the Caribbean. It was founded in 1996 and has grown to become the second-largest Canadian air carrier, and the ninth-largest airline in North America in terms of passengers carried. The airline operates an average of 425 flights per day and has 9,000 non-unionized employees.The stock plunged almost 20% earlier this month as the company said it expected revenue per available seat mile (RASM) to decline in the second quarter. The company blamed the weakness on the timing of the Easter and Passover holidays,Complete Story »

REIT Focus: Commonwealth REIT

Tue, 21 May 2013 16:57:02 EDT

By Joseph Ori:This REIT Focus is on Commonwealth REIT (CWH), a publicly traded third-party managed real estate investment trust that owns industrial and office buildings located throughout the U.S. CWH owns 445 properties with 72.7 million square feet including 8.8 million square feet of industrial and other space and 1.8 mullion square feet of office and industrial properties in Australia. CWH also owns approximately 56% of the common shares of Select Income REIT (SIR), a publicly traded REIT, which owns 25.4 million square feet of primarily net leased, single tenant office and industrial properties including 17.8 million square feet which are primarily leaseable to industrial and commercial companies on Oahu, HI. SIR is consolidated into the financial statements of CWH.As of 3/31/13, the average occupancy of its portfolio was 90%. CWH was founded in 1986, was incorporated as a REIT in the State of Maryland, is traded on the NYSE andComplete Story »

Potash Corp.: Not In A Favorable Risk-Reward Position

Tue, 21 May 2013 16:55:44 EDT

By Stock Gamer:The share price of Potash Corp. (POT) has risen by 14% over the past 30 days. At $43.72, the stock is trading near its 52-week high of $46.16 and offers a solid dividend yield at 3.2%. However, due to the recent rally, the stock valuation appears to have reverted back to the fair range, meaning a buy rating is likely not warranted. My view is based on the following 5 reasons:1. Potash shares are fully priced relative to its industry peers'. According to the table shown below, the company's 2-year consensus revenue, EBITDA, and EPS growth estimates are considerably above the peer averages, but its 5-year earnings growth estimate is only marginally better. On the profit side, Potash enjoys higher margins and fairly in-line capital return performance. In terms of leverage and liquidity, Potash carries a relatively higher debt load as reflected by its above-average debt toComplete Story »

Stocks Get A Boost From Dovish Fed Remarks

Tue, 21 May 2013 16:47:00 EDT

Remarks from a voting member of the Federal Reserve's policy-making board helped push stocks into new high ground Tuesday, with volume rising modestly. The Dow Jones industrial average rose 0.4%, while the Nasdaq and the S&P 500 each added 0.2%. Volume climbed slightly on both major exchanges, according to preliminary data. Fed Chairman Ben Bernanke is slated to testify before the Joint Economic Committee of Congress Wednesday. Ahead of his

Chesapeake Revisited: 20% Upside With Natural Gas At $4, But Little Margin Of Safety

Tue, 21 May 2013 16:41:11 EDT

By Mike Williams: Chesapeake Energy (CHK) is outperforming significantly in 2013, up about 26% as of Monday morning vs. about 17.5% for the S&P 500. Since bottoming last year in the midst of ex-CEO Aubrey McClendon's personal loans scandal and a major funding gap in the order of $10 billion, the company has shaken up its board, sold off several billion in "non-core" assets, and made progress in its transition to becoming an oil major. Lou Simpson Exits: Cause for Concern? Lou Simpson was the former CIO of GEICO, a wholly owned subsidiary of Warren Buffett's Berkshire Hathaway. Mr. Simpson was regularly touted by Buffett as a phenomenal investor with great business sense, so his presence on Chesapeake's board made me confident that the company was at least trying to do the right things. After all, why would a guy like Simpson risk his reputation by attaching himself to an inevitableComplete Story »

Gold Sinks Ahead of Bernanke Testimony

Tue, 21 May 2013 16:38:32 EDT

Gold dipped in Tuesday trading on the eve of testimony by Federal Reserve Chairman Ben Bernanke before the U.S. Congress Joint Economic Committee.

Saks shares rise on report it hired Goldman for strategic options

Tue, 21 May 2013 16:31:22 EDT

NEW YORK, May 21 (Reuters) - Shares of Saks Inc climbed higher Tuesday after the New York Post reported that the luxury department store chain hired Goldman Sachs to explore strategic alternatives,...

The Rich Investor's Secret To Buying Low

Tue, 21 May 2013 16:26:16 EDT

By Ian Wyatt: "The best thing that happens to us is when a great company gets into temporary trouble...We want to buy them when they're on the operating table." -Warren Buffett Eight months ago, investors had essentially written off Netflix (NFLX). The company lost three million subscribers and angered many others in late 2011, after a series of mind-boggling missteps by founder and CEO Reed Hastings. The bad press that ensued took a serious toll on Netflix’s stock, and the company took more than a year to recover. But as history has shown, great companies temporarily beaten down by bad press can have tremendous upside potential. You see, investors tend to think rosy thoughts when times are good. And when bad news in is the air, they are quick to expect the worst. The fact is that most investors get things wrong. Even the experts on Wall Street were wrong in telling Complete Story »

Sonova Holding's CEO Discusses Full-Year 2012/2013 Results - Earnings Call Transcript

Tue, 21 May 2013 16:25:03 EDT

Sonova Holding Ag (SONVF.PK) Full-Year 2012/2013 Results Earnings Call May 21, 2013 7:00 AM ET Executives Thomas Bernhardsgruetter – Head, IR Lukas Braunschweiler – CEO Hartwig Grevener – CFO Analysts Chris Gretler – Credit Suisse Oliver Metzger – Commerzbank Florian Gaiser – BZ Bank Lorenz Reinhard – Pictet Asset Management Hendrik Lofruthe – HSBC Presentation Thomas Bernhardsgruetter Good afternoon, everybody here in Staefa. And good morning, or good afternoon for those of you joining us on the webcast or on the conference call. My name is Thomas Bernhardsgrutter. I’m the Head of Investor Relations here at Sonova. And with me today is Lukas Braunschweiler, our CEO; and Hartwig Grevener, our CFO. For those of you on the webcast or on the telephone conference, you should have received instructions about how to ask questions. You can submit the questions via the interface of the webcast. Now the webcast will be available <a href='http://seekingalpha.com/article/1451191-sonova-holding-s-ceo-discusses-full-year-2012-2013-results-earnings-call-transcript?source=feed'>Complete Story »</a>

Kindred Healthcare Inc. - Analyst/Investor Day

Tue, 21 May 2013 16:20:07 EDT

Kindred Healthcare, Inc. (KND) May 21, 2013 10:00 am ET Executives Paul J. Diaz - Chief Executive Officer, Director and Chairman of Strategic Development Committee Benjamin A. Breier - President and Chief Operating Officer William M. Altman - Executive Vice President for Strategy, Policy and Integrated Care Gregory C. Miller - Chief Development Officer Richard A. Lechleiter - Chief Financial Officer and Executive Vice President Presentation Paul J. Diaz Good morning. Welcome to a very special day for us, so we're very excited to have so many friends and investors, shareholders here with us today. On behalf of my partners and I and our Board of Directors, many of which are with us today as well, we thank you for your continuing support of the company and, again, for attending the session today. We hope to have some fun. We hope to engage you in a dialogue and discussion about <a href='http://seekingalpha.com/article/1451181-kindred-healthcare-inc-analyst-investor-day?source=feed'>Complete Story »</a>

A Sustainable And Growing 8% Yield Is Driving NorthStar Realty Finance's Outperformance

Tue, 21 May 2013 16:17:10 EDT

By Dane Bowler:There is a fair amount of market skepticism when it comes to mREITs. Many have paid dividends in excess of the sustainable magnitude, which temporarily props up the stock price and erodes book value, leading to the eventual crash. Northstar Realty Finance (NRF), however, offers a sustainable and growing 7.99% yield. In this article we will analyze Northstar's fundamentals and demonstrate its cash flows to be sufficient to sustain the dividend. We will then examine its recent and planned activity to show tremendous growth potential. The buy thesis will then be completed with valuation analysis and addressing the counterarguments. Dividend sustainability In a previous article, in which we examined the dividend history of the legacy commercial mREITs, we revealed that NRF was the only one to pay a dividend through the entirety of the Great Recession. (click to enlarge) While this history is a nice framework fromComplete Story »